Literature DB >> 3361337

Abnormalities of autonomic function in the Lambert Eaton myasthenic syndrome.

J P Heath1, D J Ewing, R E Cull.   

Abstract

Two cases of Lambert Eaton syndrome unassociated with an underlying malignancy are described. Both had mild autonomic symptoms but markedly abnormal autonomic function tests. These results are suggestive of a widespread defect in cholinergic transmission in addition to that at the skeletal neuromuscular junction.

Entities:  

Mesh：

Year:  1988        PMID： 3361337      PMCID： PMC1032876          DOI： 10.1136/jnnp.51.3.436

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  15 in total

1.  Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors.

Authors:  L M EATON; E H LAMBERT
Journal:  J Am Med Assoc       Date:  1957-03-30

2.  Increased frequency of IgG heavy chain marker Glm(2) and of HLA-B8 in Lambert-Eaton myasthenic syndrome with and without associated lung carcinoma.

Authors:  N Willcox; A G Demaine; J Newsom-Davis; K I Welsh; S A Robb; S G Spiro
Journal:  Hum Immunol       Date:  1985-09       Impact factor: 2.850

3.  Are cardiovascular reflexes more commonly impaired in patients with bronchial carcinoma?

Authors:  G A Gould; M Ashworth; G T Lewis
Journal:  Thorax       Date:  1986-05       Impact factor: 9.139

4.  Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma.

Authors:  D Elmqvist; E H Lambert
Journal:  Mayo Clin Proc       Date:  1968-10       Impact factor: 7.616

5.  Defects of neuromuscular transmission in syndromes other than myasthenia gravis.

Authors:  E H Lambert
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

6.  Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome.

Authors:  J Newsom-Davis; N M Murray
Journal:  Neurology       Date:  1984-04       Impact factor: 9.910

7.  Autonomic dysfunction and Eaton Lambert syndrome.

Authors:  M B Mamdani; R L Walsh; F A Rubino; R T Brannegan; M H Hwang
Journal:  J Auton Nerv Syst       Date:  1985-04

8.  Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine.

Authors:  H Lundh; O Nilsson; I Rosén
Journal:  Neurology       Date:  1984-10       Impact factor: 9.910

9.  The carcinomatous neuromyopathy of oat cell lung cancer.

Authors:  R J Hawley; M H Cohen; N Saini; V W Armbrustmacher
Journal:  Ann Neurol       Date:  1980-01       Impact factor: 10.422

10.  Autoimmunity in the Lambert-Eaton myasthenic syndrome.

Authors:  V A Lennon; E H Lambert; S Whittingham; V Fairbanks
Journal:  Muscle Nerve       Date:  1982       Impact factor: 3.217
View more
  5 in total

Review 1.  Postganglionic cholinergic dysautonomia with incomplete recovery: a clinical, neurophysiological and immunological case study.

Authors:  R Baron; F Engler
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

Review 2.  Lambert-Eaton myasthenic syndrome.

Authors:  U Seneviratne; R de Silva
Journal:  Postgrad Med J       Date:  1999-09       Impact factor: 2.401

3.  Autonomic dysfunction in Lambert-Eaton myasthenic syndrome.

Authors:  S A Waterman
Journal:  Clin Auton Res       Date:  2001-06       Impact factor: 4.435

4.  Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.

Authors:  Michael T Flink; William D Atchison
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

Review 5.  Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.

Authors:  Michael T Flink; William D Atchison
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.